Boehringer Ingelheim, a Germany-based drugs company, has become a strategic partner of US-based digital health accelerator Rock Health.

Rock Health also has as corporate partners: Switzerland-based drugs group Roche’s Genentech biotech subsidiary; Alexandria Real Estate Equities, which owns biotech buildings; and public relations firm Ogilvy. Rock has 11 start-ups for its latest accelerator programme, including CRIXlabs, Apapsis and Cancer IQ – get the full list of companies from GigaOm‘s article.

And Johnson & Johnson (J&J) marked the official opening of its new innovation centre in Silicon Valley, California, with David Kirn, the founder of Jennerex, as the first entrepreneur that will be funded by the programme.  

This was the third of J&J’s innovation centres to open after Boston and London.

Separately, US-based healthcare firm BlueCross BlueShield’s global accelerator, Healthbox, has hired Mairi Johnson as its executive director. Mairi previously worked at Circle, a clinician-led secondary care provider and was a former…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?